Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Jonathan Kay MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Kay, Jonathan

Item TypeName
Academic Article Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
Academic Article E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
Academic Article Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Academic Article Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160.
Academic Article The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Concept Dose-Response Relationship, Drug
Academic Article Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
Academic Article Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.
Academic Article Enhancement of human monocyte beta-glucan receptors by glucocorticoids.

Search Criteria
  • Dose Response Relationship Drug